 "Cambridge-based AstraZeneca's vaccine is among the leading candidates in the global race for a successful vaccine")
Shares of Astrazeneca Pharma India hit fresh record high of Rs 3,900 apeice, in an otherwise weak market, up 5.15 per cent on the BSE on Friday. Woth today's rally, the stock has soared 15.18 per cent in the past eight sessions, as against 0.6 per ent decline in the S&P BSE Sensex.
At 12:02 pm, the stock of the pharma maker was ruling 4 per cent higher at Rs 3,860 on the BSE, as against 1.25 per cent decline in the Sensex index.
AstraZeneca Plc, the company's parent firm, is expected to release initial data on whether a vaccine can stop
